Articles from Xevant

Xevant, a leading provider of real-time data analytics for pharmacy benefit management, today announced the release of its 2025 Drug Price Inflation White Paper, providing key insights into the ongoing surge in pharmaceutical prices and what it means for payers, employers, and pharmacy benefit managers (PBMs).

Xevant, a leader in pharmacy benefits automation, today announces the launch of its all-new Biosimilar Dashboard, a real-time analytics tool designed to streamline biosimilar adoption and reduce unnecessary spending on biologic drugs.

As obesity rates in the United States have reached 41.9 percent among adults, Xevant has released a new e-book, Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers, designed to empower employers with the tools and insights needed to address this critical health and economic challenge. The e-book offers actionable guidance on crafting effective, sustainable corporate weight management programs that drive meaningful results for both employees and employers.

Xevant, a leader in automated analytics for the pharmacy benefits industry, today announced the launch of new AI-powered capabilities designed to revolutionize the ingestion and standardization of healthcare data. These advancements address one of the most significant challenges faced by pharmacy benefit managers (PBMs), health plans, consultants, and employers—managing the influx of diverse, complex data formats quickly and efficiently.

Xevant, a leading provider of healthcare analytics and technology solutions for the pharmacy benefit management industry, today announced the launch of its all-new GLP-1 Dashboard, designed to equip Pharmacy Benefit Managers (PBMs), payers, health plans, brokers and consultants with precise data and analytics to manage the skyrocketing costs associated with GLP-1 therapies more effectively.

Xevant, a leader in pharmacy benefits optimization, and RxPreferred, a leading transparent pharmacy benefits administrator, are excited to announce the expansion of their partnership. Aligned in both vision and product, this collaboration includes strategic co-investments and aims to provide innovative, transparent, and technology-driven solutions to improve medication accessibility and significantly reduce the overall cost of healthcare.

Xevant, the leading provider of data analytics for healthcare solutions, and Ivím Health, the industry-leading provider of GLP-1 weight loss programs, today announced a strategic partnership between the two companies introducing the first corporate-designed medical weight loss solution, Ivím at Work with Xevant, to the market. Not only will this program offer medical weight loss as a corporate benefit, but it also sets a benchmark for exemplary clinical care and broadened access to GLP-1 medications. Setting a new gold standard for employer health benefit programs, Ivím at Work will significantly reduce employer healthcare costs while optimizing health outcomes for all participating employees through the most advanced clinical approach to obesity care and medical weight management.